Your search returned 121 studies. (Get alerts for new studies):
- Dose-Intensive Chemotherapy in Combination With Chemoprotected Autologous Stem Cells for Patients With Malignant Gliomas
Conditions: Adult Giant Cell Glioblastoma - Adult Glioblastoma - Adult Gliosarcoma
1 Location available
- Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma
Conditions: Glioblastoma Multiforme/Anaplastic Astrocytoma
1 Location available
- Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)
Conditions: Glioblastoma Multiforme - Anaplastic Astrocytoma
1 Location available
- A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
Conditions: Glioblastoma Multiforme - Glioma - Astrocytoma - Brain Tumor
1 Location available
- Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
2 Locations available
- AMG 102 and Avastin for Recurrent Malignant Glioma
Conditions: Grade IV Malignant Glioma - Glioblastoma Multiforme - Gliosarcoma
1 Location available
- Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
Conditions: Recurrence of Solid Tumor - Glioblastoma Multiforme - Melanoma
3 Locations available
- A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors
Conditions: Malignant Glioma - Glioma - Glioblastoma - Glioblastoma Multiforme - Astrocytoma
1 Location available
- IMA950 Vaccine to Boost Immune Response Against Glioblastoma
Conditions: Gioblastoma Multiforme
1 Location available
- Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
Conditions: Brain Cancer - MALIGNANT GLIOMA - Glioblastoma - Anaplastic Astrocytoma (AA) - Anaplastic Oligodendroglioma (AO) - Anaplastic Oligo-astrocytoma (AOA) - Anaplastic Mixed Gliomas - Malignant Glioma NOS
3 Locations available
- PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
Conditions: Glioblastoma Multiforme - Anaplastic Glioma
2 Locations available
- Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients
Conditions: Glioblastoma Multiforme
1 Location available
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
Conditions: Adult Anaplastic Astrocytoma - Adult Anaplastic Oligodendroglioma - Adult Giant Cell Glioblastoma - Adult Glioblastoma - Adult Gliosarcoma - Adult Mixed Glioma - Adult Primary Hepatocellular Carcinoma - Chondrosarcoma - Clear Cell Sarcoma of the Kidney -
1 Location available
- Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors
Conditions: Recurrent Anaplastic Astrocytoma - Recurrent Anaplastic Oligodendroglioma - Recurrent Anaplastic Oligo-Astrocytoma - Recurrent Glioblastoma Multiforme
2 Locations available
- Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
245 Locations available
- Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)
Conditions: Glioblastoma Multiforme - Anaplastic Glioma
1 Location available
- Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
10 Locations available
- Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)
Conditions: Brain Cancer - Glioblastoma
1 Location available
- A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
Conditions: Ependymoma - Brainstem Glioma - Astrocytoma - Glioblastoma Multiforme - PNET
1 Location available
- Cellular Immunotherapy Study for Brain Cancer
Conditions: Gliomas - Anaplastic Astrocytoma - Anaplastic Oligodendroglioma - Anaplastic Mixed Glioma - Glioblastoma Multiforme
1 Location available
- Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
Conditions: Brain Neoplasms, Malignant - Brain Neoplasms, Benign - Malignant Meningioma - Glioblastoma Multiforme - Anaplastic Astrocytoma
1 Location available
- Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malig
Conditions: Adult Anaplastic Astrocytoma - Adult Anaplastic Ependymoma - Adult Anaplastic Oligodendroglioma - Adult Brain Stem Glioma - Adult Diffuse Astrocytoma - Adult Ependymoma - Adult Giant Cell Glioblastoma - Adult Glioblastoma - Adult Gliosarcoma - Adult Mixed
1 Location available
- Trial Of Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (TEMODAR) For Treatment Of Newly Diagnosed Glioblastoma Multiforme And Anapla
Conditions: Glioblastoma Multiforme - Anaplastic Astrocytoma
1 Location available
- A Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research Purposes
Conditions: Glioblastoma Multiforme - Gliosarcoma - Anaplastic Astrocytoma - Anaplastic Oligodendroglioma - Anaplastic Mixed Oligoastrocytoma
1 Location available
- Amgen 386 for Recurrent Glioblastoma
Conditions: Glioblastoma Multiforme
1 Location available
- Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
Conditions: Grade IV Glioma - Grade IV Astrocytoma - Glioblastoma Multiforme
4 Locations available
- Phase I Factorial Trial of Temozolomide, Memantine, Mefloquine, and Metformin for Post-Radiation Therapy (RT) Glioblastoma Multiforme (GBM)
Conditions: Brain Cancer
1 Location available
- Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) With Concomitant Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM)
Conditions: Glioblastoma - GBM - Glioma - High Grade Glioma
4 Locations available
- Biomarkers for Prognosis of Glioblastoma (GBM)
Conditions: Glioblastoma
1 Location available
- A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma
Conditions: Glioblastoma - Small Cell Glioblastoma - Giant Cell Glioblastoma - Gliosarcoma - Glioblastoma With Oligodendroglial Component - Recurrent Glioblastoma - Relapsed Glioblastoma
11 Locations available
- Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
Conditions: Glioblastoma Multiforme - Anaplastic Astrocytoma
1 Location available
- A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
Conditions: Mixed Gliomas - Malignant Gliomas - Glioblastoma Multiforme
1 Location available
- Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors - Cognitive/Functional Effects
18 Locations available
- Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Conditions: Glioblastoma Multiforme
18 Locations available
- Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
7 Locations available
- Radiosurgery Plus Bevacizumab in Glioblastoma
Conditions: Glioblastoma - Gliosarcoma - Brain Tumor
1 Location available
- Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)
Conditions: Glioblastoma Multiforme
1 Location available
- Dendritic Cell Vaccine for Patients With Brain Tumors
Conditions: Glioma - Anaplastic Astrocytoma - Anaplastic Astro-oligodendroglioma - Glioblastoma
1 Location available
- Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
Conditions: Glioblastoma Multiforme - GBM - Brain Cancer
3 Locations available
- Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme
Conditions: Relapsed Glioblastoma Multiforme
3 Locations available
- A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
Conditions: Glioblastoma Multiforme
16 Locations available
- Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
Conditions: Glioblastoma Multiforme
1 Location available
- Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma
Conditions: Glioblastoma
1 Location available
- Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme
Conditions: Glioblastoma Multiforme
1 Location available
- Radiosurgery for Glioblastoma
Conditions: Glioblastoma Multiforme
1 Location available
- Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities
Conditions: Glioblastoma Multiforme
1 Location available
- MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
224 Locations available
- Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery
Conditions: Primary Glial Neoplasms of Brain - Glioblastoma
1 Location available
- Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
Conditions: Adult Anaplastic Astrocytoma - Adult Anaplastic Oligodendroglioma - Adult Diffuse Astrocytoma - Adult Giant Cell Glioblastoma - Adult Glioblastoma - Adult Gliosarcoma - Adult Mixed Glioma - Adult Oligodendroglioma - Recurrent Adult Brain Tumor
1 Location available
- BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor
Conditions: GLIOBLASTOMA MULTIFORME - Brain Neoplasm
1 Location available
- A Study of a Retroviral Replicating Vector Administered to Subjects With Recurrent Malignant Glioma
Conditions: Glioblastoma - Anaplastic Astrocytoma - Anaplastic Oligodendroglioma - Anaplastic Oligoastrocytoma
4 Locations available
- A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
Conditions: Glioblastoma - Gliosarcoma - Anaplastic Astrocytoma
1 Location available
- Trial Of Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab (Bevacizumab) For Treatment Of Relapsed/Refractory Glioblastoma Multi
Conditions: Glioblastoma Multiforme - Anaplastic Astrocytoma
1 Location available
- Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
Conditions: Breast Cancer - Lung Cancer - Carcinoma, Non-Small-Cell Lung - Cancer of Brain and Nervous System - Glioblastoma
1 Location available
- Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma
Conditions: Glioblastoma
8 Locations available
- Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
1 Location available
- PET Scan Using 18F-Fluoromisonidazole and MRI In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
8 Locations available
- Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant
Conditions: Solid Tumors - Glioblastoma Multiforme - Recurrent Malignant Gliomas
2 Locations available
- Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Conditions: Glioblastoma Multiforme - GBM - Gliosarcoma
5 Locations available
- Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
Conditions: Glioblastoma Multiforme - Controls (Those Without Glioblastoma Multiforme)
1 Location available
- Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
Conditions: Giant Cell Glioblastoma - Glioblastoma - Gliosarcoma
3 Locations available
- A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Re
Conditions: Adult Anaplastic Astrocytoma - Recurrent Grade III Glioma - Recurrent Grade IV Glioma - Adult Anaplastic Oligodendroglioma - Adult Brain Tumor - Adult Giant Cell Glioblastoma - Adult Glioblastoma - Adult Gliosarcoma - Adult Mixed Glioma - Recurrent Adult
1 Location available
- Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myelom
Conditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Gastrointestinal Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer
8 Locations available
- Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)
Conditions: Glioblastoma Multiforme - Gliosarcoma
1 Location available
- A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Conditions: Glioblastoma Multiforme
23 Locations available
- AZD8055 for Adults With Recurrent Gliomas
Conditions: Glioblastoma Multiforme - Anaplastic Astrocytoma - Anaplastic Oligodendroglioma - Malignant Glioma - Brainstem Glioma
1 Location available
- Bosutinib in Adult Patients With Recurrent Glioblastoma
Conditions: Glioblastoma
2 Locations available
- Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
Conditions: Glioblastoma - Optic Neuropathy
1 Location available
- Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
Conditions: Glioblastoma
3 Locations available
- A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma
Conditions: Recurrent Glioblastoma
5 Locations available
- Natural History of Patients With Brain and Spinal Cord Tumors
Conditions: Astrocytoma - Central Nervous System Tumor - Glioblastoma - Glioma - Medulloblastoma
1 Location available
- Poliovirus Vaccine for Recurrent Glioblastoma Multiforme (GBM)
Conditions: Recurrent Supratentorial Glioblastoma Multiforme - GBM - Glioblastoma Multiforme
1 Location available
- Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
Conditions: Glioblastoma Multiforme
2 Locations available
- A Phase I/II Study of the Photon Radiosurgery System
Conditions: Brain Tumor, Recurrent - Glioblastoma Multiforme
1 Location available
- Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
Conditions: Brain and Central Nervous System Tumors
145 Locations available
- Trial of Enzastaurin and Bevacizumab in Adults With Recurrent Malignant Gliomas
Conditions: Recurrent Glioblastoma
1 Location available
- Magnetic Resonance (MR) Imaging Study Using Ferumoxytol to Assess Early Tumor Response in Patients With Glioblastoma Multiforme
Conditions: Diagnostic Imaging
1 Location available
- Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme
Conditions: Malignant Gliomas
1 Location available
- Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
Conditions: Glioblastoma
2 Locations available
- Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
Conditions: Glioblastoma - Brain Tumor
2 Locations available
- Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies
Conditions: Brain and Central Nervous System Tumors
11 Locations available
- Sunitinib to Treat Recurrent Brain Cancer
Conditions: Glioblastoma Multiforme - Malignant Gliomas - Anaplastic Gliomas
1 Location available
- A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults Wit
Conditions: Glioblastoma Multiforme - Gliosarcoma - Anaplastic Astrocytoma - Anaplastic Oligodendroglioma - Anaplastic Mixed Oligoastrocytoma
1 Location available
- Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)
Conditions: Brain Cancer - Glioblastoma Multiforme
1 Location available
- RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma
Conditions: Brain and Central Nervous System Tumors
5 Locations available
- Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme
Conditions: Glioblastoma Multiforme
1 Location available
- Super-Selective Intraarterial Cerebral Infusion of Cetuximab for the Treatment of Recurrent Glioblastoma Multiforme and Anaplastic Astrocytoma
Conditions: Glioblastoma Multiforme (GBM) - ANAPLASTIC ASTROCYTOMA (AOA)
1 Location available
- Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
Conditions: High Grade Glioma: Glioblastoma (GBM) - High Grade Glioma: Gliosarcoma - Anaplastic Astrocytoma (AA) - Anaplastic Oligodendroglioma (AO) - Mixed Anaplastic Oligoastrocytoma (AOA)
1 Location available
- Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
Conditions: Multiple Myeloma - Non-Hodgkin's Lymphoma - Glioblastoma Multiforme - Head and Neck Squamous Cell Cancer - Triple Negative Breast Cancer - Hormone Receptor-Positive Breast Cancer - Castration-Resistant Prostate Cancer - Ewing's Family of Sarcomas
2 Locations available
- E7050 in Combination With E7080 in Subjects With Advanced Solid Tumors (Dose Escalation) and in Subjects With Recurrent Glioblastoma or Unresectable S
Conditions: Advanced Solid Tumors
1 Location available
- Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
Conditions: Glioblastoma
1 Location available
- AZD7451 for Recurrent Gliomas
Conditions: Glioblastoma Multiforme - Gliosarcoma - Anaplastic Astrocyloma - Oligoastrocytoma - Malignant Glioma
1 Location available
- Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
Conditions: Glioblastoma - Small Cell Glioblastoma - Giant Cell Glioblastoma - Gliosarcoma - Glioblastoma With Oligodendroglial Component
34 Locations available
- A Study in Recurrent Glioblastoma (GB)
Conditions: Glioblastoma
4 Locations available
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Conditions: Glioblastoma Multiforme - Glioblastoma - GBM - Grade IV Astrocytoma - Glioma - Brain Cancer - Brain Tumor
40 Locations available
- Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma
Conditions: Glioblastomas - Gliosarcoma
2 Locations available
- Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
Conditions: Brain and Central Nervous System Tumors
10 Locations available
- Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytol
Conditions: Anaplastic Astrocytoma - Anaplastic Ependymoma - Anaplastic Meningioma - Anaplastic Oligodendroglioma - Brain Stem Glioma - Ependymoblastoma - Giant Cell Glioblastoma - Glioblastoma - Gliosarcoma - Grade III Meningioma - Meningeal Hemangiopericytoma - Mix
1 Location available
- PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
Conditions: Glioblastoma - GBM - Glioblastoma Multiforme
3 Locations available
- (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
Conditions: Low Grade Glioma - Glioblastoma Multiforme - Anaplastic Astrocytoma - Anaplastic Oligodendroglioma - Oligoastrocytoma
1 Location available
- Safety Study of MGA271 in Refractory Cancer
Conditions: Prostate Cancer - Pancreatic Cancer - Melanoma - Renal Cell Carcinoma - Ovarian Cancer - Colorectal Cancer - Gastric Cancer - Bladder Cancer - Non-small Cell Lung Cancer - Glioblastoma
3 Locations available
- Bevacizumab With or Without Surgery for Adult Glioblastomas
Conditions: Glioblastoma - Brain Neoplasm
1 Location available
- Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Conditions: Glioblastoma Multiforme - Anaplastic Astrocytoma - Anaplastic Oligodendroglioma - Anaplastic Oligoastrocytoma
3 Locations available
- A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma
Conditions: Glioblastoma, Glioma
1 Location available
- PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
Conditions: Glioblastoma Multiforme - Brain Metastases
1 Location available
- Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme
Conditions: Glioblastoma
1 Location available
- A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
Conditions: Glioblastoma - Gliosarcoma - Anaplastic Astrocytoma - Anaplastic Oligodendroglioma - Anaplastic Mixed Oligoastrocytoma - Malignant Astrocytoma NOS
1 Location available
- Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme
Conditions: Recurrent Glioblastoma Multiforme - Recurrent Gliosarcoma
1 Location available
- PI/II of Temozolomide & Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
Conditions: Glioblastoma - Cancer of Brain and Nervous System - Glioblastoma Multiforme
1 Location available
- Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma
Conditions: Brain Cancer
1 Location available
- Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astro
Conditions: Glioblastoma Multiforme - Anaplastic Astrocytoma
1 Location available
- White Blood Cells With Anti-EGFR-III for Malignant Gliomas
Conditions: Malignant Glioma - Glioblastoma - Brain Cancer
1 Location available
- Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide
Conditions: Glioblastoma Multiforme
2 Locations available
- Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme
Conditions: Newly Diagnosed Glioblastoma Multiforme
1 Location available
|